Guardant Health NYSE IPO

5/9/2018
IPO

Announced

5/9/2018


Overview:

  • Guardant Health, a cancer diagnostics company, aims to raise $100 million with its IPO on NYSE.

Mihail Georgiev - Data analyst

Jurisdictions:

United States
New York

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing laws:

New York
United States

Industry sector:

Pharmaceuticals and life sciences


Firm:

Party: Guardant Health Inc (Issuer)